000 01378 a2200385 4500
005 20250518095011.0
264 0 _c20210705
008 202107s 0 0 eng d
022 _a1098-9048
024 7 _a10.1055/s-0039-1700996
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShaw, Brian
245 0 0 _aPulmonary Langerhans Cell Histiocytosis.
_h[electronic resource]
260 _bSeminars in respiratory and critical care medicine
_cApr 2020
300 _a269-279 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aClinical Trials as Topic
650 0 4 _aDisease Progression
650 0 4 _aHistiocytosis, Langerhans-Cell
_xcomplications
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xetiology
650 0 4 _aLung Diseases
_xcomplications
650 0 4 _aMitogen-Activated Protein Kinases
_xgenetics
650 0 4 _aMutation
650 0 4 _aPrognosis
650 0 4 _aProto-Oncogene Proteins B-raf
_xgenetics
650 0 4 _aRespiratory Insufficiency
_xetiology
650 0 4 _aSmoking
_xadverse effects
650 0 4 _aSmoking Cessation
700 1 _aBorchers, Michael
700 1 _aZander, Dani
700 1 _aGupta, Nishant
773 0 _tSeminars in respiratory and critical care medicine
_gvol. 41
_gno. 2
_gp. 269-279
856 4 0 _uhttps://doi.org/10.1055/s-0039-1700996
_zAvailable from publisher's website
999 _c30846519
_d30846519